- Are you losing time and money preparing your regulatory submissions?
- Would you like to reduce or even eliminate rejections of your regulatory submissions?
- Would you like to optimize your revenue window associated to the patent clock?
The requirements for eCTD-compliant submissions are unique and must be applied to documents that are constantly evolving. As an Investigational New Drug Application (IND) or New Drug Application (NDA) submission is prepared, the incorporated documents are continuously under review, endlessly annotated and changing through internal and external improvements. These improvements increase the risk of corrupting the submission, creating errors in post-production re-rendering. The revenue window is linked to the patent clock; speed of submission processing can add millions to the bottom line.
Come hear about how to save money preparing your submissions while optimizing your revenue window opportunity. Join us on Tuesday, August 9, 2011, 11 am – 12 pm EST for the webinar, Pfizer on Streamlining Pharma Submissions.
Alejandro Baque, who works in enterprise collaboration and content solutions, Pfizer, will be speaking during the webinar, about his company’s experiences using Adlib to create submission-ready PDFs.
Join this complimentary webinar to learn how Adlib is helping major pharmaceutical companies, including industry leaders such as Bayer, Coley, Eli Lilly, Genentech and, of course, Pfizer, our guest speaker at this webinar.
(You may also wish to download our white paper, Optimizing Regulatory Submission Processing to Increase Revenue through Improved Speed Time to Market.)
I’m looking forward to answering your questions on August 9th!